SIBIONO GENETECH
SiBiono is a pioneer in the field of gene therapy industry in China. The self-developed product recombinant Ad-p53 adenovirus injection (now Gendicine) was awarded the new drug certificate issued by the State Food and Drug Administration on October 16, 2003, and was produced on January 20, 2004. Approved, passed the drug GMP certification on March 11, 2004, becoming the world's first new gene therapy drug that has been officially approved for marketing, making gene therapy a new treatment for ca... ncer therapy. The birth of "this life is born again" is an important representative of China's independent innovation in science and technology. It is regarded as a milestone for China to catch up with the West and has received worldwide attention. With its strong R&D capabilities, Cybino has undertaken a number of national biotech projects, including the National 973 Program 863 Program, the National Tenth Five-Year National Science and Technology Project, the National Innovation Fund Project, and the National Ninth Five-Year Plan. Local government's high-tech industry plan. Up to now, the company has applied for 7 relevant invention patents for independent innovation achievements, involving key intellectual property rights such as product invention, production process invention.
SIBIONO GENETECH
Industry:
Biotechnology
Founded:
1998-01-01
Address:
Shenzhen, Guangdong, China
Country:
China
Website Url:
http://www.sibiono.com
Status:
Active
Contact:
(086)0755-33065208
Email Addresses:
[email protected]
Official Site Inspections
http://www.sibiono.com
- Host name: smail77.cn4e.com
- IP address: 218.5.76.77
- Location: China
- Latitude: 24.4798
- Longitude: 118.0819
- Timezone: Asia/Shanghai

More informations about "SiBiono GeneTech"
深圳市赛百诺基因技术有限公司
赛百诺公司是中国基因治疗产业领域的开拓者。其自主研制开发的产品重组Ad-p53腺病毒注射液(今又生/Gendicine)于2003年10月16日获得国家食品药品监督管理局颁发的新药证 …See details»
深圳市赛百诺基因技术有限公司 - sibiono.com
赛百诺公司简介. 赛百诺公司是中国基因治疗产业领域的开拓者。其自主研制开发的产品重组Ad-p53腺病毒注射液(今又生/Gendicine)于2003年10月16日获得国家食品药品监督管理局颁发 …See details»
深圳市赛百诺基因技术有限公司
Sibiono GeneTech Co. Ltd., Shenzhen (Sibiono), is the world's innovator and leader in gene therapy. It was opened at the Shenzhen High-tech Industrial Park in March 1998. In Oct 16, …See details»
SiBiono GeneTech - Crunchbase Company Profile & Funding
SiBiono is a pioneer in the field of gene therapy industry in China. The self-developed product recombinant Ad-p53 adenovirus injection (now Gendicine) was awarded the new drug …See details»
Shenzhen SiBiono GeneTech Co. Ltd.
了解Shenzhen SiBiono GeneTech Co. Ltd. (深圳市赛百诺基因技术有限公司)公司的药物管线,治疗领域,技术平台,以及它的10项临床试验, 16篇新闻和6篇文献,疾病领域:肿瘤,技术平台: …See details»
赛百诺基因技术有限公司 - 百度百科
深圳市赛百诺基因技术有限公司以增进人类健康,提高生活质量为企业使命,是中国在基因治疗领域的开拓者。十年来赛百诺公司承担多项国家及省级创新研究开发项目。2003年10月16日, …See details»
SiBiono Company Profile | Management and Employees List
SiBiono Profile and History. General Hospital and Harvard Hospital too. Before that, he worked for 5 top universities hospitals in China. Then he leads his medical team to America and Europe …See details»
SiBiono GeneTech - Crunchbase
SiBiono is a pioneer in the field of gene therapy industry.See details»
Introduction - sibiono.com
Sibiono GeneTech Co. Ltd., Shenzhen (Sibiono), is the world's innovator and leader in gene therapy. It was opened at the Shenzhen High-tech Industrial Park in March 1998. In Oct 16, …See details»
Shenzhen Sibiono GeneTech Co., Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Shenzhen Sibiono GeneTech Co., Ltd. of Shenzhen, Guangdong. Get the latest business insights from …See details»
SIBIONO Trademark of Shenzhen Sibiono GeneTech Co., Ltd.
Filed in October 12 (2017), the SIBIONO covers Advertising and publicity services; Advertising services; Business management assistance; Commercial administration of the licensing of the …See details»
SiBiono - Company Profile - Tracxn
Aug 20, 2024 SiBiono ranks 61st among 86 active competitors. 21 of its competitors are funded while 8 have exited. Overall, SiBiono and its competitors have raised over $250M in funding …See details»
Four Cell & Gene Companies to Know in China
Oct 30, 2020 China, Cell & Gene Therapy, Company Spotlight, Sibiono GeneTech, JW Therapeutics, Fosun Kite, UniCAR. While cell and gene therapies are all the rage now, a little …See details»
SiBiono GeneTech - Tech Stack, Apps, Patents & Trademarks
Organization. SiBiono GeneTech . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 5. About. SiBiono …See details»
About us - sibiono.com
Sibiono’s discovery and pre-clinical development team is actively looking for opportunities to collaborate with external partners even at very early stages of discovery. Joint development of …See details»
Chinese Firm Develops Gene Therapy Injection - China.org.cn
SiBiono is located in Shenzhen's Nanshan High-tech Zone. Gendicine uses an adenoviral vector to carry p53 tumor suppressor genes to tumor cells. It is widely believed that P53 is the most …See details»
SiBiono Genetech - Products, Competitors, Financials, Employees ...
The 247-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also …See details»
SSTEC - sibiono.com
Sibiono Science and Technology Experts Committee (SSTEC) is major administrative measure for the strengthening of S&T basis and the maintainance of an expert panel within the …See details»
Login
Only registered members are allowed to access this section. Please login below or register an account with Sibionus.See details»
R&D - sibiono.com
Sibiono has already acquired the invention patents necessary for lab to large scale development technology in gene therapy drugs. With the successful platforms so built and operated, Sibiono …See details»